论文部分内容阅读
在第十二届哈洽会上,龙庆集团的科技新中药引起了国内外客商的极大关注。日本、韩国、马来西亚等国外客商纷纷到龙庆医保展位前品尝后,要求在本国成立经营代销产品机构,认为龙庆医保系列产品有着广阔的市场发展前景。此次哈洽会共签订意向性协议2.4亿元人民币。哈洽会结束后,已有俄罗斯、韩国、香港等地客商来人来电,与龙庆企业商讨洽谈签订代销产品合同和合作项
At the 12th Harbin Meeting, the new scientific and new Chinese medicines of Longqing Group attracted great attention from domestic and foreign merchants. Foreign merchants from Japan, South Korea, Malaysia and other countries have come to the Longqing Medical Insurance Exhibition Center before tasting. They are required to establish an agency agency in their own country. They believe that Longqing Medicare series products have broad market prospects. The Harbin Fair has signed a total of 240 million yuan in intentional agreements. After the conclusion of Harbin Fair, there have been merchants from Russia, South Korea, Hong Kong and other places who have come to negotiate with Longqing enterprises to negotiate and sign contracts for product sales and cooperation.